On Monday, Tandem Diabetes Care Inc (NASDAQ: TNDM) opened higher 4.47% from the last session, before settling in for the closing price of $31.35. Price fluctuations for TNDM have ranged from $13.82 to $53.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 36.59% over the past five years. Company’s average yearly earnings per share was noted 49.98% at the time writing. With a float of $64.95 million, this company’s outstanding shares have now reached $65.55 million.
Let’s look at the performance matrix of the company that is accounted for 2400 employees. In terms of profitability, gross margin is 49.06%, operating margin of -17.47%, and the pretax margin is -16.5%.
Tandem Diabetes Care Inc (TNDM) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Tandem Diabetes Care Inc is 0.79%, while institutional ownership is 113.66%. The most recent insider transaction that took place on May 30 ’24, was worth 258,400. In this transaction Director of this company sold 5,000 shares at a rate of $51.68, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 27 ’23, when Company’s Director bought 5,000 for $18.96, making the entire transaction worth $94,778. This insider now owns 19,962 shares in total.
Tandem Diabetes Care Inc (TNDM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 49.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.80% during the next five years compared to -6.11% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Check out the current performance indicators for Tandem Diabetes Care Inc (TNDM). In the past quarter, the stock posted a quick ratio of 2.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.09, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.18 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Inc (NASDAQ: TNDM) saw its 5-day average volume 1.37 million, a negative change from its year-to-date volume of 1.6 million. As of the previous 9 days, the stock’s Stochastic %D was 13.68%. Additionally, its Average True Range was 2.00.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 9.02%, which indicates a significant decrease from 22.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.85% in the past 14 days, which was lower than the 61.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $40.80, while its 200-day Moving Average is $37.46. Nevertheless, the first resistance level for the watch stands at $33.42 in the near term. At $34.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $35.05. If the price goes on to break the first support level at $31.79, it is likely to go to the next support level at $30.82. Assuming the price breaks the second support level, the third support level stands at $30.16.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
There are currently 64,590K shares outstanding in the company with a market cap of 2.14 billion. Presently, the company’s annual sales total 747,720 K according to its annual income of -222,610 K. Last quarter, the company’s sales amounted to 221,910 K and its income totaled -30,810 K.
